Ignite Creation Date:
2024-05-06 @ 3:02 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02187367
Status:
TERMINATED
Last Update Posted:
2019-09-10
First Post:
2014-07-07
Brief Title:
Safety Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive Wild Type EGF-R NSCLC Patients
Sponsor:
Bioven Europe
Organization:
Bioven Sdn Bhd
Organization Data
Organization:
Bioven Sdn Bhd
Class:
INDUSTRY
Study ID:
BV-NSCLC-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bioven Europe
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None